A 20-Year-Old Man with IgA Vasculitis following COVID-19 Vaccination.

Abdulaziz Alsubaie, Abdulmajeed Alshabanat, Abdulrahman Almizel, Mohammed Omair, Rahaf Alodaini

Open access · goldAbstract readCase Reports

In one paragraph

Article in Case reports in rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 71% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Abdulaziz AlsubaieKing Saud University College of Medicine, Department of Infectious Diseases, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-8074-6862

Abdulmajeed AlshabanatKing Saud University College of Medicine, Department of Internal Medicine, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-8594-5051

Abdulrahman AlmizelDepartment of Medicine, McGill University, Montreal, QC, Canada.

Mohammed OmairKing Saud University College of Medicine, Department of Internal Medicine, Riyadh, Saudi Arabia.

Rahaf AlodainiKing Saud University College of Medicine, Department of Internal Medicine, Riyadh, Saudi Arabia.

King Saud University · SAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA vasculitis is a common type of vasculitis that is generally triggered by infectious causes. Vaccines have been reported as a trigger as well. Herein, we report a case of a young man who is previously healthy and who developed IgA vasculitis after the first dose of the COVID-19 mRNA vaccine Pfizer-BioNTech. The patient's symptoms were mainly skin and joint without renal or other system involvement. The patient had an excellent outcome with complete resolution after treatment with steroid tapering and azathioprine as a steroid-sparing agent over 6 months.

Identifiers

PMID37492803

DOI10.1155/2023/9505383

PMCPMC10365908

OpenAlexW4384498149

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.